SCHEMBL6529233

SCHEMBL6529233

CCCCCCOc1ccc(-c2ccc(CCC(COC(C)=O)(COC(C)=O)CC(N)=O)c(OC)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 5/20 0.41
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
RARB P10826 3/20 0.40
S1PR4 O95977 4/20 0.39
S1PR3 Q99500 4/20 0.39
S1PR5 Q9H228 3/20 0.39
PLA2G4B P0C869 1/20 0.38
LMNA P02545 1/20 0.37
MMP9 P14780 1/20 0.37
MMP8 P22894 1/20 0.37
MMP13 P45452 1/20 0.37
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 1/20 0.36
THRA P10827 1/20 0.36
THRB P10828 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6502330 0.86 RARB (0.45) S1PR1RARBS1PR4S1PR3S1PR5
SCHEMBL6532174 0.85 PDE4A (0.45) S1PR1CNR2S1PR4S1PR3S1PR5
SCHEMBL6530994 0.83 S1PR1 (0.43) S1PR1RARBS1PR4S1PR3S1PR5
SCHEMBL6529006 0.82 S1PR1 (0.44) S1PR1CNR1CNR2S1PR4S1PR3
SCHEMBL6529691 0.81 SLC13A5 (0.43) S1PR1RARBS1PR4S1PR3S1PR5
SCHEMBL6529754 0.80 ESR1 (0.38) S1PR1RARBMEN1KMT2ATHRA
SCHEMBL6530516 0.78 SLC13A5 (0.53) S1PR1S1PR4S1PR3S1PR5PLA2G4B
SCHEMBL6530176 0.76 S1PR1 (0.45) S1PR1RARBS1PR4S1PR3S1PR5
SCHEMBL6504731 0.75 S1PR1 (0.47) S1PR1RARBS1PR4S1PR3S1PR5
SCHEMBL6529533 0.75 S1PR1 (0.56) S1PR1RARBS1PR4S1PR3S1PR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005014525-A2 BI-ARYL COMPOUND HAVING IMMUNOSUPPRESSIVE ACTIVITY MITSUBISHI PHARMA CORPORATION (JP) 2005-02-17 WO disclosed